Questions? +1 (202) 335-3939

Trusted News Since 1995

A service for global professionals · Monday, January 6, 2025 · 774,514,641 Articles · 3+ Million Readers

Got News to Share? Send 2 FREE Releases ↓

News Search | All News Topics > FDA News Topics: By Country | By State ; Press Releases by Industry Channel > All FDA Press Releases

NUWIQ

STN: BL 125555
Proper Name: Antihemophilic Factor (Recombinant)
Tradename: NUWIQ
Manufacturer: Octapharma USA, Inc.
Indication:

Indicated in adults and children with Hemophilia A for:
- On-demand treatment and control of bleeding episodes
- Perioperative management of bleeding
- Routine prophylaxis to reduce the frequency of bleeding episodes

Product Information

Supporting Documents

Distribution channels: Healthcare & Pharmaceuticals Industry

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Submit your press release

Food & Drug Administration News Today by EIN Newsdesk & EIN Presswire (a press release distribution service)

Newsmatics Inc., 1025 Connecticut Avenue NW, Suite 1000, Washington, DC 20036 · Contact · About